Zolimidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171971This classification denotes an anti-ulcer agent with the molecular formula C14H12N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YCF001N8QB, chemically known as 2-(p-(methylsulfonyl)phenyl)imidazol(1,2-a)pyridine but generally known as zolimidine, which bears US NIH Compound Identifier 14652. European Medicines Agency schedules Zolimidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00179MIG. The term ZOLIMIDINE is an International Non-Proprietary Name. World Health Organization schedules zolimidine in its Anatomical Therapeutic Chemical (ATC) Classification. ZOLIMIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zolimidine under HS 29339990 and SITC 51577. As of Q4 2014, ZOLIMIDINE remains the US FDA Preferred Term for this commodity. Zolimidine bears US NLM identifiers UMLS ID C0650163 and NCI Concept Code C66705. SMILES: S(=O)(=O)(C1CCC(C2NC3N(C2)CCCC3)CC1)C.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.